Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Type Strain
no
Preceptrol®
no
Comments
experimental infection in mice
Medium
ATCC® Medium 325: Malt extract agar (Blakeslee's formula)
Growth Conditions
Temperature: 25.0°C
Name of Depositor
P Warn
Special Collection
NCRR Contract
Chain of Custody
ATCC <<--P Warn<<--C. Moore
Isolation
lung of patient with leukemia who had an intermediate response to amphotericin B but whose aspergillosis later relapsed, Manchester, England
References
Johnson EM, et al. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J. Antimicrob. Chemother. 45: 85-93, 2000. PubMed: 10629017
Verweij PE, et al. Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis. Antimicrob. Agents Chemother. 42: 873-878, 1998. PubMed: 9559799
Denning DW, Warn P. Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B. Antimicrob. Agents Chemother. 43: 2592-2599, 1999. PubMed: 10543734
